Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sorafenib in Patients With Hepatopulmonary Syndrome: A Double-Blind Randomized Clinical Trial

Next Previous
X
Search
Trial Profile

Sorafenib in Patients With Hepatopulmonary Syndrome: A Double-Blind Randomized Clinical Trial

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 26 Apr 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sorafenib (Primary)
  • Indications Liver disorders; Lung disorders
  • Focus Therapeutic Use
  • Acronyms SHPS

    • Most Recent Events

    • 28 Feb 2019 Primary endpoint (Difference in changes in alveolar-arterial oxygen gradient between sorafenib and placebo groups) has not been met published in the Liver transplantation
    • 28 Feb 2019 Results assessing effect of sorafenib in patients with hepatopulmonary syndrome on the alveolar-arterial oxygen gradient published in the Liver Transplantation
    • 14 Mar 2018 Status changed from recruiting to discontinued.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top